Ilypsa, Inc.
5301 Patrick Henry Drive
Santa Clara
California
95054
United States
Tel: 408-200-9500
Fax: 408-200-9700
Website: http://www.ilypsa.com/
Email: pr@ilypsa.com
9 articles about Ilypsa, Inc.
-
Amgen Completes Acquisition of Ilypsa, Inc.
7/19/2007
-
Ilypsa, Inc. Announces Promotion of Paul A. Stone to Senior Vice President, General Counsel and Chief Patent Counsel
5/1/2007
-
Ilypsa, Inc. Completes Enrollment of Phase 2 Clinical Trial of ILY101 For Patients With Chronic Kidney Disease On Hemodialysis
2/6/2007
-
Ilypsa, Inc. Announces Promotion Of Gerrit Klaerner, Ph.D. To Senior Vice President And Chief Business Officer
12/12/2006
-
Ilypsa, Inc. Appoints Samuel R. Saks, M.D. To Board Of Directors
12/5/2006
-
Ilypsa, Inc. Announces Appointment Of William D. Waddill As Chief Financial Officer
10/26/2006
-
Ilypsa, Inc. And Astellas Pharma Inc. Enter A Licensing Agreement On ILY101 For Treatment Of Hyperphosphatemia In Japan; Astellas To Pay Ilypsa $92 Million
4/27/2006
-
Ilypsa, Inc. Completes Phase 1 Clinical Trial Of ILY101 For Hyperphosphatemia Associated With Chronic Kidney Disease
4/20/2006
-
Ilypsa, Inc. Announces Appointment Of Jay P. Shepard As President And CEO
1/5/2006